2023 annual financial data
Monte Rosa Therapeutics 2023 Net income growth
Direct answer
Net income growth was -24.75%.
Operating income was -143,311,000 USD and net income was -135,352,000 USD.
Operating cash flow was -43,802,000 USD.
Get free Monte Rosa Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -143,311,000 USD
- Net income
- -135,352,000 USD
- Operating cash flow
- -43,802,000 USD